Topic: IIS Data > Data Use

Preliminary Guidance on Serologic Testing

Issued on October 29, 2020 by AIRA

Preliminary Guidance on Serologic Testing
The purpose of this preliminary guidance developed by an SISC small workgroup is to assist IIS, EHR vendors, and other stakeholders in preparing for the technical requirements of creating HL7 messages containing serologic results as proof of immunity during the COVID-19 response. This document contains vocabulary definitions, standards, and test cases. It is being published in a preliminary format and will be updated as necessary.